DK0906918T3 - Fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cystinbroer - Google Patents

Fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cystinbroer

Info

Publication number
DK0906918T3
DK0906918T3 DK98115048T DK98115048T DK0906918T3 DK 0906918 T3 DK0906918 T3 DK 0906918T3 DK 98115048 T DK98115048 T DK 98115048T DK 98115048 T DK98115048 T DK 98115048T DK 0906918 T3 DK0906918 T3 DK 0906918T3
Authority
DK
Denmark
Prior art keywords
correctly connected
cysteine bridges
insulin precursors
extracting insulin
extracting
Prior art date
Application number
DK98115048T
Other languages
Danish (da)
English (en)
Inventor
Reinhold Dr Keller
Franz-Josef Dl Rubroeder
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK0906918T3 publication Critical patent/DK0906918T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK98115048T 1997-08-18 1998-08-11 Fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cystinbroer DK0906918T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19735711A DE19735711C2 (de) 1997-08-18 1997-08-18 Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Publications (1)

Publication Number Publication Date
DK0906918T3 true DK0906918T3 (da) 2002-09-09

Family

ID=7839275

Family Applications (2)

Application Number Title Priority Date Filing Date
DK98115048T DK0906918T3 (da) 1997-08-18 1998-08-11 Fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cystinbroer
DK99115386T DK0980874T3 (da) 1997-08-18 1998-08-11 Forbedret fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cysteinbroer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK99115386T DK0980874T3 (da) 1997-08-18 1998-08-11 Forbedret fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cysteinbroer

Country Status (20)

Country Link
US (3) US5986048A (cs)
EP (2) EP0980874B1 (cs)
JP (1) JP4291900B2 (cs)
KR (2) KR100537842B1 (cs)
CN (3) CN1483831B (cs)
AR (1) AR016821A1 (cs)
AT (2) ATE217636T1 (cs)
AU (1) AU744824B2 (cs)
BR (2) BRPI9816233B8 (cs)
CA (1) CA2245151C (cs)
CZ (1) CZ295679B6 (cs)
DE (3) DE19735711C2 (cs)
DK (2) DK0906918T3 (cs)
ES (2) ES2176870T3 (cs)
HU (2) HU228203B1 (cs)
ID (1) ID20717A (cs)
PL (1) PL191901B1 (cs)
PT (2) PT980874E (cs)
RU (2) RU2205836C2 (cs)
TR (1) TR199801587A2 (cs)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
AU2151401A (en) 1999-12-22 2001-07-03 Novo Nordisk A/S Method for extractive refolding of scrambled single-chain polypeptides
US20030212248A1 (en) * 2000-07-12 2003-11-13 Furman Thomas Charles Process to increase protein stability
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
DE102004015965A1 (de) * 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
EP1973942B1 (en) 2005-12-22 2011-02-09 Genentech, Inc. Recombinant production of heparin binding proteins
SG162834A1 (en) 2006-07-14 2010-07-29 Genentech Inc Refolding of recombinant proteins
KR20110016430A (ko) * 2007-07-03 2011-02-17 암젠 인코퍼레이티드 봉입체 건량을 이용한 단백질 측정
RU2451750C2 (ru) * 2007-09-24 2012-05-27 Общество С Ограниченной Ответственностью "Герофарм" Способ получения рекомбинантного с-пептида проинсулина человека
ES2613152T3 (es) 2008-01-09 2017-05-22 Sanofi-Aventis Deutschland Gmbh Nuevos derivados de insulina con perfil tiempo/acción extremadamente retardado
WO2009133529A2 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Processes for refolding of insulin
CR20170369A (es) 2008-10-17 2017-11-01 Sanofi Aventis Deutschland COMBINACIÓN DE UNA INSULINA Y UN AGONISTA DE GLP-1 (Divisional 2011-0188)
WO2011058082A1 (de) 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten und methionin
PL2498802T3 (pl) 2009-11-13 2015-06-30 Sanofi Aventis Deutschland Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę
SG187904A1 (en) 2010-08-30 2013-04-30 Sanofi Aventis Deutschland Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
US12157766B2 (en) * 2012-08-05 2024-12-03 Absci Corporation Cytoplasmic expression system
WO2014099577A1 (en) 2012-12-17 2014-06-26 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
PE20151409A1 (es) * 2013-02-26 2015-10-07 Hanmi Pharm Ind Co Ltd Analogo de insulina novedoso y su uso
CN103694339B (zh) * 2013-12-04 2017-10-13 珠海联邦制药股份有限公司 一种甘精胰岛素前体的复性方法
US10407483B2 (en) 2014-03-14 2019-09-10 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
EP3229828B1 (en) 2014-12-12 2023-04-05 Sanofi-Aventis Deutschland GmbH Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
CN104911203A (zh) * 2015-06-30 2015-09-16 成都易胜科生物科技有限公司 一种重组人胰岛素的工业制备方法
EP3344651B1 (en) 2015-09-02 2022-03-02 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds
WO2017205309A1 (en) * 2016-05-25 2017-11-30 Merck Sharp & Dohme Corp. Insulin receptor partial agonists
WO2018018613A1 (zh) 2016-07-29 2018-02-01 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
CN113773391B (zh) * 2020-06-09 2023-10-20 宁波鲲鹏生物科技有限公司 一种门冬胰岛素的制备方法
CN113773400B (zh) * 2020-06-09 2023-08-18 宁波鲲鹏生物科技有限公司 一种门冬胰岛素衍生物及其应用
CN113773396A (zh) * 2020-06-10 2021-12-10 宁波鲲鹏生物科技有限公司 一种地特胰岛素衍生物及其应用
JP7749397B2 (ja) * 2021-09-30 2025-10-06 キヤノン株式会社 超音波ファントム及び超音波ファントムの製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DE3501641A1 (de) * 1985-01-19 1986-07-24 Hoechst Ag, 6230 Frankfurt Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen
GR1005153B (el) * 1989-08-29 2006-03-13 The General Hospital Corporation Πρωτεινες συντηξεως, παρασκευη τους και χρηση τους.
RU2045535C1 (ru) * 1991-06-18 1995-10-10 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН Способ получения проинсулина человека
ES2097426T3 (es) * 1992-12-02 1997-04-01 Hoechst Ag Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos.
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
RU2081122C1 (ru) * 1994-06-16 1997-06-10 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН Способ выделения и очистки инсулина или его биотехнологических предшественников
JP4624495B2 (ja) * 1994-12-29 2011-02-02 フェリング・インターナショナル・センター・エス.・エー. ヒト・インスリンの生成
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Also Published As

Publication number Publication date
CN1132845C (zh) 2003-12-31
ES2176870T3 (es) 2002-12-01
BR9803755A (pt) 2000-03-28
KR19990023651A (ko) 1999-03-25
RU2302882C2 (ru) 2007-07-20
CN1483831B (zh) 2012-06-13
CZ295679B6 (cs) 2005-09-14
HK1061870A1 (en) 2004-10-08
DE59804121D1 (de) 2002-06-20
US6380355B1 (en) 2002-04-30
US20020156234A1 (en) 2002-10-24
CN101186940A (zh) 2008-05-28
US5986048A (en) 1999-11-16
JPH11130798A (ja) 1999-05-18
KR20050067371A (ko) 2005-07-01
HU0600287D0 (en) 2006-05-29
AU8076398A (en) 1999-02-25
EP0906918A3 (de) 1999-08-11
ID20717A (id) 1999-02-18
RU2205836C2 (ru) 2003-06-10
DE59803985D1 (de) 2002-06-06
DE19735711A1 (de) 1999-02-25
HU228203B1 (en) 2013-01-28
CN1483831A (zh) 2004-03-24
PL328108A1 (en) 1999-03-01
HUP9801886A2 (hu) 1999-01-28
BRPI9816233B1 (pt) 2016-09-27
CN101186940B (zh) 2012-02-08
ES2177178T3 (es) 2002-12-01
PT906918E (pt) 2002-10-31
US6727346B2 (en) 2004-04-27
PL191901B1 (pl) 2006-07-31
JP4291900B2 (ja) 2009-07-08
CZ259898A3 (cs) 1999-03-17
DE19735711C2 (de) 2001-04-26
DK0980874T3 (da) 2002-08-19
EP0906918B1 (de) 2002-05-15
KR100574580B1 (ko) 2006-04-28
HK1119449A1 (en) 2009-03-06
EP0980874B1 (de) 2002-05-02
ATE217636T1 (de) 2002-06-15
CA2245151A1 (en) 1999-02-18
TR199801587A3 (tr) 1999-03-22
KR100537842B1 (ko) 2006-03-23
PT980874E (pt) 2002-10-31
TR199801587A2 (xx) 1999-03-22
HUP9801886A3 (en) 1999-06-28
CA2245151C (en) 2009-10-06
HU228161B1 (en) 2013-01-28
EP0980874A1 (de) 2000-02-23
ATE217012T1 (de) 2002-05-15
CN1209437A (zh) 1999-03-03
HU9801886D0 (en) 1998-10-28
AR016821A1 (es) 2001-08-01
HK1018464A1 (en) 1999-12-24
AU744824B2 (en) 2002-03-07
BRPI9816233B8 (pt) 2021-05-25
EP0906918A2 (de) 1999-04-07

Similar Documents

Publication Publication Date Title
DK0906918T3 (da) Fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cystinbroer
FI950699L (fi) Menetelmä insuliinin saamiseksi, jossa on oikein sitoutuneet kystiinisillat
DK1015388T3 (da) Fremgangsmåde til inhibering af biogen sulfiddannelse
DK1011309T3 (da) Fremgangsmåde til tilvejebringelse af forøget fotosyntese
DK0998473T3 (da) Krystalmodifikation af et N-phenyl-2-pyrimidinaminderivat, fremgangsmåder til fremstilling deraf samt dets anvendelse
DE59909597D1 (de) Verfahren zur kontrolle der insulinmedikation
DK1914244T3 (da) Fremgangsmåde til at modulere aktiviteten af funktionelle immunmolekyler.
DE69835798D1 (de) Verfahren um dünnschichtbauelemente zu transferieren
DK0960558T3 (da) Fremgangsmåder til frembringelse af udbyttekort
NO20003050D0 (no) Metode for Õ administrere monomere insulinanaloger
DE69735527D1 (de) Digitales Verfahren zur adaptiven Taktrückgewinnung
DK0936912T3 (da) Inhibitorer af cysteinprotease
DK1036179T3 (da) Fremgangsmåde til fremstilling af polypeptider med egnet glucosilering
DK1194226T3 (da) Apparat til forhydrolyse af biomasse samt dets anvendelse
DK1032565T3 (da) Fremgangsmåde til fremstilling af derivater af taxoid-klassen
DK1230247T3 (da) Fremgangsmåde til stabilisering af siloxanforbindelser
DK1508666T3 (da) Fremgangsmåde og apparat til fuldførelse af brønde med sidegrene
DE60035731D1 (de) Vorrichtung zur Taktrückgewinnung
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DE69835190D1 (de) Schaltung zur Taktrückgewinnung
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK1308454T3 (da) Fremgangsmåde til fremstilling af platinforbindelse
DK0749677T3 (da) Fremgangsmåde til fremskaffelse af data
FR2777096B3 (fr) Horloge
DK1062358T3 (da) Ny fremgangsmåde til fremstilling af fexofenadin